0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Propranolol Controversy

John D. Archer, MD; Mary Ellen Kosman, PhD
JAMA. 1974;227(2):201-202. doi:10.1001/jama.1974.03230150049020.
Text Size: A A A
Published online

To the Editor.—  The letter of Doctor Fisch (226:1009, 1973) requires some comment, although his remarks concerning the labeling of propranolol for use in angina pectoris are now somewhat anachronistic. Almost simultaneously with the Commentary on propranolol by the Department of Drugs, the manufacturer obtained approval from the Food and Drug Administration (FDA) to include the treatment of angina pectoris among the labeled indications for the drug. There actually have been a substantial number of well-controlled studies to support this use, and these surely were taken into consideration by the FDA in its action. We believe, however, that the Department's monograph succeeded better than the government-approved labeling in placing the proper role of the drug in perspective. For example, the physician relying solely on the manufacturer's package insert could be left confused and uncertain about the continuing importance of sublingual nitrates in the management of the disease.All that, however,

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

* * SCHEDULED MAINTENANCE * *

Our websites may be periodically unavailable between midnight and 04:00 ET Thursday, July 10th, for regularly scheduled maintenance.

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();